Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition
暂无分享，去创建一个
Jianji Wang | Bahar Inankur | E. Simmons | Steven A. Tymonko | Jun Li | Maxime C Soumeillant | Adam Freitag | D. Treitler | Joerg Deerberg | Chris Sfouggatakis | Federico Lora Gonzalez | J. H. Simpson | Michael Dummeldinger | Michael J. Smith | S. Kolotuchin | Collin Chan | T. Benkovics | D. S. Treitler | D. Lin | Amanda Rogers | Ke Chen | Amanda J. Rogers